NCT04636853View on ClinicalTrials.gov

CB-PRP in Retinitis Pigmentosa and Dry Age-related Macular Degeneration

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 23, 2020

Primary Completion Date

December 1, 2021

Study Completion Date

December 2, 2021

Conditions
Retinitis PigmentosaDry Age-related Macular Degeneration
Interventions
BIOLOGICAL

Subretinal injection of umbilical cord blood platelet-rich plasma (CB-PRP)

"A subretinal injection of umbilical cord blood platelet-rich plasma (CB-PRP) will be performed only in one eye, the other eye will be considered as a control group.~A complete morpho-functional ophthalmological evaluation will be performed in all patient at each control."

Trial Locations (1)

00168

Alfonso Savastano, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT04636853 - CB-PRP in Retinitis Pigmentosa and Dry Age-related Macular Degeneration | Biotech Hunter | Biotech Hunter